70% Of Antibiotics Not Working On Patients: Expert

Pune: Noted intensivists from across the country recently gathered in the city to speak at an international symposium on the increasing need for awareness of antimicrobial resistance (AMR).

The 12th annual Best of Brussels symposium was organised by the Indian Society of Critical Care Medicine, Pune chapter. The three-day symposium, ‘Best of Brussels’, started last Friday and a media briefing on the same was held on Saturday.

Dr Shirish Prayag, council member, Sepsis Forum, an NGO, said that it has been observed over the years that about 70% of current antibiotics used to treat various infections are not working on patients. This has led to increased mortality among patients, requiring critical care, by 30%. City-based intensivist Dr Kapil Zirpe said that sepsis would be the leading cause of deaths in the country by 2050 as there is a 7-8% increase year-on-year in outpatients, and 11% among indoor patients who are reporting repeated infections.

Dr Tanu Singhal, consultant paediatrics and infectious diseases, Kokilaben Dhirubhai Ambani Hospital, said “The pipeline of newer drugs is slower and soon we will be in era of pre-antibiotics, where no antibiotics will be left to treat infections.”

Dr Yatin Mehta, chairman, Medanta Institute of Critical Care and Anaesthesiology, said, “Every hospital should have antibiotic stewardship programmes, which should be strictly followed.”

Dr Subhal Dixit, joint organising secretary, Best of Brussels, said, “Data from WHO or Surviving Sepsis guidelines state that 50 million patients were admitted in ICUs across the world due to sepsis. In India, we expect the rates to double by 2050.”

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks